2Anderson H,Hopwood P,Stephens RJ,et al.Gemcitabine plus best supportive care vs BSC in inoperable non-small cell lung cancer-a randomized trial with quality of life as the primary outcome[J].Br J Cancer,2000,83:447～453.
3The Elderly Lung Cancer Vinorelbine Italian Study Group.Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer[J].J Natl Cancer Inst,1999,91:66～72.
4Shepherd FA,Dancey J,Ramlau R,et al.Prospective randomized trial of docetaxel versus best supportive care in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy[J].J Clin Oncol,2000,18:2095～2103.
5Ranson M,Davidson N,Nicolson M,et al.Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer[J].J Natl Cancer Inst,2000,92:1074～1080.
6Camps C,Massuti B,Jimenez AM,et al.Two second -line docetaxel dose-schedules in advanced non-small cell lung cancer (NSCLC):a Spanish Lung Cancer Group (SLCG) phase Ⅲ trial[J].Lung Cancer,2003,41:S5.
7Schuette W,Nagel S,Serke M,et al.Second-line chemotherapy for advanced non-small cell lung cancer (NSCLC) with weekly versus three-weekly docetaxel:results of a randomized phase Ⅲstudy[J].Proc Am Soc Clin Oncol,2004,23:622.
8Georgoulias V,Papadakis E,Alexopoulos A,et al.Platinum based and non-platinum-based chemotherapy in advanced non -small cell lung cancer:a randomized multicenter trial[J].Lancet,2001,357:1478～1484.
9Rosemary Y, Lynn AGR. Cancer in older persons: an internal issue in an aging world [J]. Semin Oncol, 2004, 31 (2) : 128 - 136.
10Yee KW, Pater JL,Pho L, et al. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? [J]. Clin Oncol, 2003, 21(8) : 1618 -1623.
5Kazuaki. A hybrid technique: video - assisted thoracoscopic surgery(VATS) pulmonary resections for community -based surgeons [ J ]. Surgical En- doscopy, 2010,24 (3) : 700 - 704.
6Hesketh PJ, Lilenbanm RC, Chansky K, et al. Chemotherapy in patients ≥80 with advanced non-small cell lung cancer: com- bined results from SWOG 0027 and LUN 6 [ J ]. J Thorac Oncol, 2007, 2:494-498.
7Tokujiro Y, Affiliations Koji Y, Riichiroh M, et al. Feasibility study of postoperative adjuvant chemotherapy with S-1 ( tegaful, gimeracil, oteracil potassium)for non-small cell lung cancer LOGIK 0601 study[J]. Lung Cance, 2010, 32:184-187.
